Telbivudine - Investigational Drug for Chronic Hepatitis B Infection

 
Key Data:
Drug (brand / generic)
Telbivudine
Company / licensee
Idenix Pharmaceuticals / Novartis Pharma
Therapy class
Nucleotide analogue
Product description
Oral L-deoxythymidine
Current indication
Chronic HBV infection
Market sector
Antiinfectives
Development status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development